Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| 1 |
AstraZeneca
AZN
|
+$810M |
| 2 |
Intuitive Surgical
ISRG
|
+$705M |
| 3 |
S&P Global
SPGI
|
+$439M |
| 4 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
+$361M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$253M |
Top Sells
| 1 |
Broadcom
AVGO
|
+$605M |
| 2 |
FedEx
FDX
|
+$587M |
| 3 |
Monster Beverage
MNST
|
+$395M |
| 4 |
McDonald's
MCD
|
+$387M |
| 5 |
Booking.com
BKNG
|
+$380M |
Sector Composition
| 1 | Technology | 22.3% |
| 2 | Consumer Discretionary | 16.25% |
| 3 | Healthcare | 15.51% |
| 4 | Financials | 12.99% |
| 5 | Communication Services | 11.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
426
Nutrien
NTR
$27.9B
| $15.5M | 0.01% |
268,071
+31,991
| +14% | +$1.85M |
|
427
ProPetro Holding
PUMP
$505M
| $15.4M | 0.01% |
934,913
-1,381,033
| -60% | -$22.8M |
|
|
ALLK
428
DELISTED
Allakos
ALLK
| $15.4M | 0.01% |
+341,802
| New | +$15.4M |
|
|
EIGR
429
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $15.2M | 0.01% |
42,133
+250
| +0.6% | +$90K |
|
430
Agios Pharmaceuticals
AGIO
$2.07B
| $15.1M | 0.01% |
195,370
+1,435
| +0.7% | +$111K |
|
|
TSRO
431
DELISTED
TESARO, Inc.
TSRO
| $14.9M | 0.01% |
382,114
-3,634
| -0.9% | -$142K |
|
432
MPLX
MPLX
$50.8B
| $14.9M | 0.01% |
428,264
-660,227
| -61% | -$22.9M |
|
433
Freeport-McMoran
FCX
$64.4B
| $14.8M | 0.01% |
1,062,837
-55,205
| -5% | -$768K |
|
434
Spyre Therapeutics
SYRE
$977M
| $14.7M | 0.01% |
61,296
+278
| +0.5% | +$66.5K |
|
435
BrightView Holdings
BV
$1.31B
| $14.6M | 0.01% |
912,179
+21,491
| +2% | +$345K |
|
|
RDC
436
DELISTED
Rowan Companies Plc
RDC
| $14.3M | 0.01% |
757,793
+260,965
| +53% | +$4.91M |
|
|
CTLT
437
DELISTED
CATALENT, INC.
CTLT
| $14.1M | 0.01% |
+309,627
| New | +$14.1M |
|
438
Elanco Animal Health
ELAN
$9.11B
| $14M | 0.01% |
+400,000
| New | +$14M |
|
|
OLBK
439
DELISTED
Old Line Bancshares, Inc.
OLBK
| $13.7M | 0.01% |
434,273
+421,421
| +3,279% | +$13.3M |
|
|
SYNH
440
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $13.7M | 0.01% |
266,116
-64,090
| -19% | -$3.3M |
|
|
GSKY
441
DELISTED
GreenSky, Inc. Class A Common Stock
GSKY
| $13.5M | 0.01% |
751,710
-48,290
| -6% | -$869K |
|
|
EQM
442
DELISTED
EQM Midstream Partners, LP
EQM
| $13.4M | 0.01% |
253,824
+10,949
| +5% | +$578K |
|
|
PARA
443
DELISTED
Paramount Global Class B
PARA
| $13.4M | 0.01% |
+232,638
| New | +$13.4M |
|
444
Diamondback Energy
FANG
$40.4B
| $13M | 0.01% |
+96,201
| New | +$13M |
|
|
AM
445
DELISTED
ANTERO MIDSTREAM PARTNERS LP
AM
| $13M | 0.01% |
453,080
+18,544
| +4% | +$531K |
|
446
Kosmos Energy
KOS
$832M
| $12.8M | 0.01% |
1,367,583
+366,528
| +37% | +$3.43M |
|
447
Box
BOX
$4.74B
| $12.8M | 0.01% |
534,387
-2,243
| -0.4% | -$53.6K |
|
448
Constellium
CSTM
$2.02B
| $12.7M | 0.01% |
1,030,000
-265,508
| -20% | -$3.28M |
|
449
Eaton
ETN
$141B
| $12.5M | 0.01% |
144,458
-143,984
| -50% | -$12.5M |
|
450
Alcoa
AA
$8.01B
| $12.2M | 0.01% |
300,764
-18,258
| -6% | -$738K |
|